Emerging role of lncRNAs in systemic lupus erythematosus

Publication date: October 2018Source: Biomedicine &Pharmacotherapy, Volume 106Author(s): Chan-Na Zhao, Yan-Mei Mao, Li-Na Liu, Xiao-Mei Li, De-Guang Wang, Hai-Feng PanAbstractLong non-coding RNAs (lncRNAs), defined as ≥200 base pairs in length but have little translation potential, play a key role in imprinting control, immune cell differentiation, apoptosis and immune responses. Recently, many potential lncRNAs have been revealed to contribute to a new layer of molecular regulation of systemic lupus erythematosus (SLE). Immune-related functional lncRNAs may serve as novel therapeutic targets and disease biomarkers to provide potential support for clinic treatment in this disease. In this review, we will briefly introduce the identification, biogenesis and functions of lncRNAs, and summarize recent advance in the role of lncRNAs in SLE.
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research

Related Links:

Agnes Gardet, Alex Pellerin, Christie-Ann McCarl, Rohan Diwanji, Wenting Wang, Douglas Donaldson, Nathalie Franchimont, Victoria P. Werth, Dania Rabah
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
We present the first case of autochthonous VL mimicking SLE in Santa Catarina in southern Brazil.
Source: Revista da Sociedade Brasileira de Medicina Tropical - Category: Tropical Medicine Source Type: research
AbstractObjectiveLupus nephritis (LN) is a major determinant of morbidity and mortality in systemic lupus erythematosus (SLE). Pim ‐1 regulates lymphocyte proliferation and activation. The role of Pim‐1 in autoimmune disease remains unclear. Therefore, we hypothesize that Pim‐1 inhibition would have therapeutic potential for LN.MethodsWe first analyzed Pim ‐1 expression in lupus‐prone NZB/W F1 mice (n=6), in human peripheral blood mononuclear cells (PBMCs) of SLE patients (n=10), and in the glomeruli of LN patients (n=8). The therapeutic effect of Pim‐1 inhibitor AZD1208 was assessed in this lupus model (n=10/g...
Source: Arthritis and Rheumatology - Category: Rheumatology Authors: Tags: Full Length Source Type: research
(MedPage Today) -- Worse than in rheumatoid arthritis or lupus
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
Comparing gut bacteria from lupus patients with bacteria from their healthy peers, scientists learned those with lupus had about five times more of the bacteria known as Ruminococcus gnavus.
Source: WebMD Health - Category: Consumer Health News Source Type: news
WEDNESDAY, Feb. 20, 2019 -- The microbiome of patients with systemic lupus erythematosus (SLE), particularly those with increased disease activity, has reduced taxonomic complexity, according to a study published online Feb. 19 in the Annals of the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
In this report, we present a rare case of congestive heart failure after vaginal delivery. The patient was diagnosed with systemic lupus erythematosus and LS endocarditis based on the transesophageal echocardiographic and laboratory findings. After steroid therapy, the vegetations on the mitral valve disappeared and mitral regurgitation reduced dramatically without a cardiac surgery. The patient achieved long-term clinical improvement at 3-year follow-up. Immunosuppressive therapy could be an effective treatment for acute congestive heart failure induced by LS endocarditis.
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
WEDNESDAY, Feb. 20, 2019 -- An imbalance in the gut " microbiome " of people with lupus may be driving the chronic autoimmune disease as well as its flare-ups, new research suggests. The microbiome is the trillions of helpful bacteria that coexist in...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Scientists have pinpointed gut bacteria that may cause painful flareups in people with Lupus, and this discovery that could lead to finding a better treatment for the condition, a new study says.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
Publication date: Available online 18 February 2019Source: Neuroscience LettersAuthor(s): Mohammad Mahdi Eftekharian, Rezvan Noroozi, Alireza Komaki, Mehrdokht Mazdeh, Mohammad Taheri, Soudeh Ghafouri-FardAbstractThe lncRNA Growth arrest-specific 5 (GAS5) has crucial roles in the apoptosis, suppression of cell growth and regulation of response to glucocorticoids. Previous studies have demonstrated its role in the pathogenesis of some immune-related disorders such as systemic lupus erythematosus and multiple sclerosis (MS). In the current study, we genotyped two possibly functional GAS5 polymorphisms (rs2067079 and rs6790) ...
Source: Neuroscience Letters - Category: Neuroscience Source Type: research
More News: Drugs & Pharmacology | Lupus